APEX Healthcare ETF 

As of 05/25/2022
Primary Exchange
Cboe BZX Exchange
Inception Date
Net Assets
Shares Outstanding
Distribution Rate
Closing Market Price
Premium Discount
30 Day Median Bid/Ask Spread
Investment Overview
Fund Objective
Seeks to provide investment results that correspond generally, before fees and expenses, to the performance of the MarketGrader Global Health Care Leaders Index.
Investment Strategy

The Fund will utilize the MarketGrader Global Health Care Leaders Index for security selection. The Index constituents are selected on the basis of the strength of their fundamentals as measured by the MarketGrader Score (zero to 100). To be eligible for inclusion in the index, a company must have a minimum market capitalization of $500 million at the time of inclusion and a minimum three-month average daily trading volume of $2 million.

Management Team

Investment Partner
Anfield Capital Management
Anfield Capital

Anfield Capital is comprised of a team of investment management executives from top-flight institutions. Our highly experienced team of 12 professionals has nearly 300 years of combined experience with the Anfield principals working together as a team for over 25 years.

Top Holdings as of 05/25/2022

Market Value % Name Market Price Shares Held Market Value
12.97%ISHARES GLOBAL HEALTHCARE$83.879,324$782,003.88
5.46%MERCK & CO$93.753,510$329,062.50
5.00%VERTEX PHARM$270.841,114$301,715.76
4.69%REGENERON PHARM$690.88409$282,569.92
4.68%PFIZER INC$53.715,250$281,977.50
4.42%ABBVIE INC$151.961,754$266,537.84
4.42%HOYA CORP$13,715.002,472$266,312.77
4.19%BIONTECH SE$154.671,634$252,730.78
4.14%DANAHER CORP$250.32997$249,569.04


Advisor Fee Total Expense Ratio Total Expense Cap
0.75% 1.13% 0.90%
*The Fund’s Adviser has contractually agreed to reduce the Fund’s fees and/or absorb expenses of the Fund until at least November 30, 2022 to ensure that the net annual fund operating expenses will not exceed 0.90%.

The median bid-ask spread is calculated by identifying the national best bid and national best offer (“NBBO”) for each fund as of the end of each 10 second interval during each trading day of the last 30 calendar days and dividing the difference between each such bid and offer by the midpoint of the NBBO. The median of those values is identified and that value is expressed as a percentage rounded to the nearest hundredth.

Investors should carefully consider the investment objective, risks, charges and expenses of ETF Funds. This and other information is contained in the prospectus and should be read carefully before investing. For a prospectus please call 866-866-4848 or visit our website at regentsparkfunds. com. Regents Park Funds are distributed by Northern LightsDistributors, LLC, member FINRA/SIPC. Northern Lights Distributors, LLC and Regents Park Funds, LLC are not affiliated.
New funds provide a limited history of operations for investors to evaluate. As with all funds, there is a risk that you could lose money through your investment in these Funds. Many factors affect the Fund’s net asset value and performance. There is no guarantee that the investment will achieve its objectives, generate profits or avoid losses. The use of derivative instruments involves risks different from, or possibly greater than, the risks associated with investing directly in securities and other traditional investments. Investing in commodities or futures markets may subject the Fund to greater volatility than investments in traditional securities. These risks include (i) leverage risk (ii) risk of mispricing or improper valuation; and (iii) the risk that changes in the value of the futures contract may not correlate perfectly with the underlying index. There are risks associated with the sale and purchase of call and put options through the Fund’s underlying investments. The use of derivative instruments could lead to potentially greater gains, as well as the potential for greater losses than a fund that does not use derivatives.